£78.71

Springer Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment: Proceedings of the Fifth International Workshop on Breast Cancer ... in Experimental Medicine and Biology)

Price data checked 2 days ago

View at Amazon

Price History & Forecast

Last 89 days • 89 data points

Historical
Generating forecast...
£79.14 £78.67 £78.77 £78.87 £78.98 £79.08 £79.18 05 February 2026 27 February 2026 21 March 2026 12 April 2026 04 May 2026

Price Distribution

Price distribution over 89 days • 1 price levels

Days at Price
89 days 0 22 45 67 89 £79 Days at Price

Price Analysis

Most common price: £79 (89 days, 100.0%)

Price range: £79 - £79

Price levels: 1 different prices over 89 days

Description

Session I.- Breast Mucin and Associated Antigens in Diagnosis and Therapy.- Peptide Epitopes in Breast Cancer Mucins.- Does a Novel Form of the Breast Cancer Marker Protein, MUC1, Act as a Receptor Molecule that Modulates Signal Transduction?.- Cancer Metastasis Determined by Carbohydrate-Mediated Cell Adhesion.- Experimental Immunotherapy of Breast Cancer Using Alpha Interferon Conjugated to Monoclonal Antibody Mc5.- Circulating and Tissue Markers in the Longitudinal Management of Breast Cancer Patients.- Session II.- Engineering of Antibodies for Breast Cancer Therapy: Construction of Chimeric and Humanized Versions of the Murine Monoclonal Antibody BrE-3.- Humanization of an Anti-Mucin Antibody for Breast and Ovarian Cancer Therapy.- Towards an Immunotherapy for p185HER2 Overexpressing Tumors.- Session III.- Branching N-Linked Oligosaccharides in Breast Cancer.- Specificity of the IgG Response in Mice and Human Breast Cancer Patients Following Immunization Against Synthetic Sialyl-Tn, an Epitope with Possible Functional Significance in Metastasis.- Vaccination Against Breast Cancer - Studies in an Animal Model.- Anti-Idiotype Antibodies as Potential Therapeutic Agents for Human Breast Cancer.- The Simultaneous Expression of c-erbB-2 Oncoprotein and Laminin Receptor on Primary Breast Tumors has a Predicting Potential Analogous to that of the Lymph Node Status.- Multivariate Prognostic Model for Infiltrating Ductal Carcinoma of the Breast in the Axillary Node-Free Patient.- The Use of Monoclonal Antibody Immunoconjugates in Cancer Therapy.- Radioimmunolocalization of Breast Cancer Using BrE-3 Monoclonal Antibody.- Suppression of Human Anti-Mouse Antibody Response to Murine Monoclonal Antibody L6 by Deoxyspergualin: A Phase I Study.- Overview of Radioimmunotherapy in Advanced Breast Cancer Using 1-131 Chimeric L6.- Contributors.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
01 June 1994
Listed Since
14 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Cell Signaling & Molecular Targets in Cancer
78% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
78% match

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Springer

£127.59 04 May 2026
Breast Cancer Pathophysiology: An Interdisciplinary Approach: 5 (Interdisciplinary Cancer Research, 5)
78% match

Breast Cancer Pathophysiology: An Interdisciplinary Approach: 5 (Interdisciplinary Cancer Research, 5)

Springer

£154.66 04 May 2026
Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects
78% match

Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects

Springer

£147.11 04 May 2026
Praxisbuch Gynäkologische Onkologie
77% match

Praxisbuch Gynäkologische Onkologie

Springer

£89.12 04 May 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
77% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.70 04 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
77% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 04 May 2026
Protease Inhibitors as Cancer Chemopreventive Agents
77% match

Protease Inhibitors as Cancer Chemopreventive Agents

Springer

£79.15 04 May 2026
Experimental and Applied Immunotherapy
77% match

Experimental and Applied Immunotherapy

Humana

£140.31 04 May 2026
Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)
76% match

Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)

Springer

£137.00 04 May 2026
Practical Guide to Hereditary Breast and Ovarian Cancer III: Annual Meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2023: 3
76% match

Practical Guide to Hereditary Breast and Ovarian Cancer III: Annual Meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2023: 3

Springer

£72.86 04 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
76% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.29 04 May 2026
Breast Care: A Clinical Guidebook for Women’s Primary Health Care Providers
75% match

Breast Care: A Clinical Guidebook for Women’s Primary Health Care Providers

Springer

£109.92 04 May 2026
Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)
75% match

Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)

Springer

£53.53 04 May 2026
Management of Early Stage Breast Cancer: Basics and Controversies
75% match

Management of Early Stage Breast Cancer: Basics and Controversies

Springer

£73.10 04 May 2026
Cell Signaling & Molecular Targets in Cancer
75% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 May 2026
Clinical Ophthalmic Oncology: Retinoblastoma
75% match

Clinical Ophthalmic Oncology: Retinoblastoma

Springer

£70.21 04 May 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
75% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.64 04 May 2026
74% match

CDK4/6 inhibitors in Breast Cancer Therapy

Academic Press

£153.99 04 May 2026
Precision Medicine in Oncology
74% match

Precision Medicine in Oncology

Wiley-Blackwell

£132.63 04 May 2026
Bioactive Components of Human Milk: 501 (Advances in Experimental Medicine and Biology, 501)
74% match

Bioactive Components of Human Milk: 501 (Advances in Experimental Medicine and Biology, 501)

Springer

£159.37 04 May 2026
Oncogene and Transgenics Correlates of Cancer Risk Assessments: Proceedings of a NATO ARW Held in Vouliagmeni Beach, Attiki, Greece, October 7-11, 1991: v. 232 (NATO Science Series A: Life Sciences)
74% match

Oncogene and Transgenics Correlates of Cancer Risk Assessments: Proceedings of a NATO ARW Held in Vouliagmeni Beach, Attiki, Greece, October 7-11, 1991: v. 232 (NATO Science Series A: Life Sciences)

Springer

£71.17 04 May 2026
Cancer II: 28 (Topics in Medicinal Chemistry, 28)
74% match

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Springer

£199.19 04 May 2026
Molecular Aspects of Cancer and Its Therapy (Molecular and Cell Biology Updates)
74% match

Molecular Aspects of Cancer and Its Therapy (Molecular and Cell Biology Updates)

Birkhauser

£80.56 04 May 2026